Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris

Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris

Abstract Background Extracorporeal membrane oxygenation (ECMO) was frequently used to treat patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory distress (ARDS) during the initial outbreak. Care of COVID-19 patients evolved markedly during the second part of 2020. Ou...

Full description

Bibliographic Details
Main Authors: Matthieu Schmidt, Elise Langouet, David Hajage, Sarah Aissi James, Juliette Chommeloux, Nicolas Bréchot, Petra Barhoum, Lucie Lefèvre, Antoine Troger, Marc Pineton de Chambrun, Guillaume Hékimian, Charles-Edouard Luyt, Martin Dres, Jean-Michel Constantin, Muriel Fartoukh, Pascal Leprince, Guillaume Lebreton, Alain Combes, for the GRC RESPIRE Sorbonne Université
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Critical Care
Subjects:
Extracorporeal membrane oxygenation
Venovenous ECMO
Acute respiratory distress syndrome (ARDS)
COVID-19
SARS-CoV-2
Outcomes
Online Access:https://doi.org/10.1186/s13054-021-03780-6

Internet

https://doi.org/10.1186/s13054-021-03780-6

Similar Items